FDA药品溶出方法数据库
(FDA-Recommended Dissolution Methods Database)
药品通用名称 剂型 USP溶出装置 速度 溶出介质 介质体积 建议取样时间(分钟) 更新日期
Fenofibrate Capsule (Micronized) Develop a dissolution method 2023/09/15
Fenofibrate (40 mg and 120 mg) Tablet Develop a dissolution method 2023/09/15
Fenofibrate (48 mg and 145 mg) Tablet Develop a dissolution method 2023/09/15
Fenofibrate (54 mg and 160 mg) Tablet Develop a dissolution method 2023/09/15
Fenofibric Acid Tablet II (Paddle) 75 Phosphate buffer, pH 6.8 900 5, 15, 30, 45 and 60 2010/08/05
Fenoprofen Calcium Capsule Refer to USP 2008/11/25
Fentanyl Transdermal VII (Reciprocating holder)- cylinder. 30 cycles per minute. amplitude of about 2m. Equimolar mixture of 0.005 M phosphoric acid solution, and 0.005 M sodium phosphate, monobasic monohydrate (pH ~ 2.6). at 32° C. Change the test samples into fresh pre-equilibrated release medium at the time points indicated. Remove the protective liner and place the film onto a piece of nylon netting with adhesive facing the net. Secure the netting and transdermal system using nylon tie wraps at the top and bottom of the cylinder on the holder. The adhesive side faces towards the media. 250 mL for the 75 and 100 mcg/hr, 200 mL for the 50 mcg/hr and 150 mL for the 25 and 12.5 mcg/hr dosage strength. 0.5, 1, 2, 4 and 24 hours 2011/06/09
Fentanyl Citrate Tablet (Sublingual) II (Paddle) 50 Phosphate Buffer, pH 6.8 500 1, 3, 5, 7, 10, 15 and 20 2013/08/15
Fentanyl Citrate Lozenges II (Paddle) 175 0.1 M Phosphate Buffer, pH 4.5 500 5, 10, 20, 30 and 40 2009/05/20
Fentanyl Citrate (0.1 mg and 0.4 mg) Tablet (Buccal) II (Paddle) small volume dissolution apparatus 100 Phosphate Buffered Saline solution, pH 7.0 100 3, 5, 7.5, 10, 15 and 20 2009/11/20
Fentanyl Citrate (0.2 mg, 0.3 mg, 0.6 mg and 0.8 mg) Tablet (Buccal) II (Paddle) small volume dissolution apparatus 100 Phosphate Buffered Saline solution, pH 7.0 200 3, 5, 7.5, 10, 15 and 20 2009/11/20
Fentanyl Citrate (0.2 mg, 0.4 mg, 0.6 mg and 0.8 mg) Film (Buccal) I (Basket) 100 mL dissolution vessel 100 25-mM Phosphate Buffer, pH 6.4 60 5, 10, 15, 20, 30 and 45 2009/12/15
Fentanyl Citrate (1.2 mg) Film (Buccal) I (Basket) 100 mL dissolution vessel 100 25-mM Phosphate Buffer, pH 6.4 100 5, 10, 15, 20, 30 and 45 2009/12/15
Ferric Citrate Tablet II (Paddle) 100 EDTA media ( 2.0 grams of EDTA Na2 2H2O to 1000 mL of purified water) 900 10, 20, 30, 45 and 60 2015/08/27
Ferric Maltol Capsule II (Paddle with sinker) 75 Tier 1: KCl/HCl Buffer, pH 1.2; Tier 2: KCl/HCl Buffer pH 1.2, with pepsin 1000 5, 10, 20, 30 and 45 2020/01/30
Ferrous Fumarate Tablet Refer to USP 2016/03/17
Fesoterodine Fumarate Tablet (Extended Release) II (Paddle) with sinker 75 Phosphate Buffer, pH 6.8 900 1, 2, 4, 6, 8, 10, 12, 16 and 20 hours 2013/08/15
Fexinidazole Tablet II (Paddle) 75 0.1 N HCl with 3% w/v SLS 2000 10, 20, 30, 40, 50 and 60 2023/05/18
Fexofenadine HCl Tablet II (Paddle) 50 0.001 N HCl 900 5, 10, 20, 30 and 45 2004/02/19
Fexofenadine HCl Capsule Develop a dissolution method 2023/09/15

数据库说明:

当前数据更新日期:2026年02月09日。
©2006-2026 DrugFuture->FDA-Recommended Dissolution Methods Database